These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

117 related articles for article (PubMed ID: 27974284)

  • 1. Decreased responsiveness following lithium discontinuation in bipolar disorder: A naturalistic observation study.
    Cakir S; Yazıcı O; Post RM
    Psychiatry Res; 2017 Jan; 247():305-309. PubMed ID: 27974284
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Reasons for lithium discontinuation in men and women with bipolar disorder: a retrospective cohort study.
    Öhlund L; Ott M; Oja S; Bergqvist M; Lundqvist R; Sandlund M; Salander Renberg E; Werneke U
    BMC Psychiatry; 2018 Feb; 18(1):37. PubMed ID: 29415689
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Recurrence following discontinuation of 28 years of lithium therapy].
    Wegmann SD; Kessing LV
    Ugeskr Laeger; 2011 Mar; 173(11):820-1. PubMed ID: 21402017
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Discontinuing lithium maintenance treatment in bipolar disorders: risks and implications.
    Baldessarini RJ; Tondo L; Viguera AC
    Bipolar Disord; 1999 Sep; 1(1):17-24. PubMed ID: 11256650
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Bouncing back: is the bipolar rebound phenomenon peculiar to lithium? A retrospective naturalistic study.
    Franks M; Macritchie KA; Mahmood T; Young AH
    J Psychopharmacol; 2008 Jun; 22(4):452-6. PubMed ID: 18635725
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Long-term lithium prophylaxis in the bipolar affective disorder].
    Suwalska A; Chłopocka-Woźniak M; Rybakowski J
    Psychiatr Pol; 2002; 36(6 Suppl):63-9. PubMed ID: 12647423
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Predictors of prophylactic response to lithium].
    Rohayem J; Baylé JF; Richa S
    Encephale; 2008 Sep; 34(4):394-9. PubMed ID: 18922242
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The Pharmacogenomics of Bipolar Disorder study (PGBD): identification of genes for lithium response in a prospective sample.
    Oedegaard KJ; Alda M; Anand A; Andreassen OA; Balaraman Y; Berrettini WH; Bhattacharjee A; Brennand KJ; Burdick KE; Calabrese JR; Calkin CV; Claasen A; Coryell WH; Craig D; DeModena A; Frye M; Gage FH; Gao K; Garnham J; Gershon E; Jakobsen P; Leckband SG; McCarthy MJ; McInnis MG; Maihofer AX; Mertens J; Morken G; Nievergelt CM; Nurnberger J; Pham S; Schoeyen H; Shekhtman T; Shilling PD; Szelinger S; Tarwater B; Yao J; Zandi PP; Kelsoe JR
    BMC Psychiatry; 2016 May; 16():129. PubMed ID: 27150464
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Prophylactic efficacy of lithium, valproic acid, and carbamazepine in the maintenance phase of bipolar disorder: a naturalistic study.
    Peselow ED; Clevenger S; IsHak WW
    Int Clin Psychopharmacol; 2016 Jul; 31(4):218-23. PubMed ID: 26523730
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Course of illness and pattern of recurrences in patients with affective disorders during long-term lithium prophylaxis: a retrospective analysis over 15 years.
    Berghöfer A; Kossmann B; Müller-Oerlinghausen B
    Acta Psychiatr Scand; 1996 May; 93(5):349-54. PubMed ID: 8792904
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Starting lithium prophylaxis early v. late in bipolar disorder.
    Kessing LV; Vradi E; Andersen PK
    Br J Psychiatry; 2014 Sep; 205(3):214-20. PubMed ID: 25012681
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Controlled lithium discontinuation in bipolar patients with good response to long-term lithium prophylaxis.
    Yazici O; Kora K; Polat A; Saylan M
    J Affect Disord; 2004 Jun; 80(2-3):269-71. PubMed ID: 15207941
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Risk of recurrence following discontinuation of lithium treatment in bipolar disorder.
    Suppes T; Baldessarini RJ; Faedda GL; Tohen M
    Arch Gen Psychiatry; 1991 Dec; 48(12):1082-8. PubMed ID: 1845226
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Valproic acid, valproate and divalproex in the maintenance treatment of bipolar disorder.
    Macritchie KA; Geddes JR; Scott J; Haslam DR; Goodwin GM
    Cochrane Database Syst Rev; 2001; (3):CD003196. PubMed ID: 11687047
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effectiveness of restarting lithium treatment after its discontinuation in bipolar I and bipolar II disorders.
    Tondo L; Baldessarini RJ; Floris G; Rudas N
    Am J Psychiatry; 1997 Apr; 154(4):548-50. PubMed ID: 9090344
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Does tachyphylaxis occur after repeated antidepressant exposure in patients with Bipolar II major depressive episode?
    Amsterdam JD; Shults J
    J Affect Disord; 2009 May; 115(1-2):234-40. PubMed ID: 18694599
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Mood stabilizer augmentation in apparently "unipolar" MDD: predictors of response in the naturalistic French national EPIDEP study.
    Hantouche EG; Akiskal HS; Lancrenon S; Chatenêt-Duchêne L
    J Affect Disord; 2005 Feb; 84(2-3):243-9. PubMed ID: 15708422
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Continuation versus discontinuation of lithium in recurrent bipolar illness: a naturalistic study.
    Biel MG; Peselow E; Mulcare L; Case BG; Fieve R
    Bipolar Disord; 2007 Aug; 9(5):435-42. PubMed ID: 17680913
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Risk of recurrence of bipolar disorder in pregnant and nonpregnant women after discontinuing lithium maintenance.
    Viguera AC; Nonacs R; Cohen LS; Tondo L; Murray A; Baldessarini RJ
    Am J Psychiatry; 2000 Feb; 157(2):179-84. PubMed ID: 10671384
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Lithium prophylaxis in early-onset Bipolar disorder: a descriptive study.
    Selvarajan S; Manohar H; Das S; Sakkarabani P; Kandasamy P
    Asian J Psychiatr; 2019 Aug; 44():172-174. PubMed ID: 31394485
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.